Forensic scientists can find crime-solving evidence in the tiniest details, such as the insects that arrive at the scene to feed on the decomposing corpse.
It's not just government-sponsored medical research that's dwindled in the last few years in the U.S. Drug firms have curbed their investment, too, especially in early-stage hunts for new drugs.
The topics for study didn't matter much to people who said they were willing to share. Every category — ranging from safety issues to health costs — scored at least 90 percent in the NPR poll.
Researchers have developed a powerful method for growing human cells in the laboratory that has led to some unusual findings. Cell tests suggest a malaria drug might work against cervical cancer.
Scientists are growing mock organs made of human cells to better study diseases and help test drugs. Researchers at Johns Hopkins are working on a gut-on-a-chip.
A line of immortal cells, supposedly from a breast cancer patient, turned out to be from a type of skin cancer. The mix-up wasn't discovered until experiments around the world had been contaminated.
A previously unknown form of botulinum toxin thought to be resistant to standard treatment raised public health concerns. Subsequent research has allayed those fears.
Inside the lab, a lone technician sorts through new samples, snipping off swab heads intentionally fouled with fecal material. One head goes to cold storage and the other is processed for sequencing.
The National Institutes of Health has approved requests for waivers from a moratorium on experiments that aim to make the virus that causes Middle East respiratory syndrome more infectious in mice.